Catalyst Pharmaceuticals (CPRX) Inventory Average (2019 - 2026)

Catalyst Pharmaceuticals has reported Inventory Average for 8 years, with the latest figure at $36.0 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory Average rose 83.36% year-over-year to $36.0 million; the trailing twelve-month figure through Mar 2026 stood at $36.0 million (up 83.36% YoY), and the FY2025 full-year result was $28.4 million, up 61.17% from the prior year.
• Inventory Average for Q1 2026 stood at $36.0 million, up from $32.6 million in the prior quarter.
• The five-year high for Inventory Average was $36.0 million in Q1 2026, with the low at $7.0 million in Q4 2022.
• Historically, Inventory Average has averaged $16.3 million across 5 years, with a median of $17.8 million in 2024.
• Annual changes were most pronounced in 2022 — Inventory Average declined 5.96% — and 2024, when it soared 107.77%.
• Catalyst Pharmaceuticals' Inventory Average stood at $7.0 million in 2022, then jumped by 77.08% to $12.3 million in 2023, then soared by 60.29% to $19.8 million in 2024, then soared by 64.81% to $32.6 million in 2025, then rose by 10.59% to $36.0 million in 2026.
• The last three Inventory Average figures came in at $36.0 million (Q1 2026), $32.6 million (Q4 2025), and $23.3 million (Q3 2025), per Business Quant data.